VIRGINIA COMMONWEALTH UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 10K

Market Cap: -

Website: http://www.vcu.edu

Clinical Trials

Violence Prevention Study for Youth Age 10-15

Not Applicable

Terminated

Conditions: Violence, Non-accidental

Interventions: Behavioral: Brief Violence Awareness
Behavioral: Brief Violence Prevention

First Posted Date: 2015-03-19

Last Posted Date: 2017-11-29

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 22

Registration Number: NCT02393092

Locations: 🇺🇸
VCU Pediatric Emergency Department, Richmond, Virginia, United States
🇺🇸
MLK Middle School Boys and Girls Club, Richmond, Virginia, United States

Hemosonics- VCU Cardiac Surgery Clinical Study

Completed

Conditions: Cardiopulmonary Bypass

Interventions: Device: Coagulation function

First Posted Date: 2015-03-18

Last Posted Date: 2016-07-12

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 52

Registration Number: NCT02392247

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

A Collaborative Public/Private Employment Training and Placement Model ASD Transition Age Youth With Autism Spectrum Disorder (ASD)

Not Applicable

Completed

Conditions: Autism Spectrum Disorder

Interventions: Behavioral: Project SEARCH plus ASD Supports

First Posted Date: 2015-02-10

Last Posted Date: 2015-02-10

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 54

Registration Number: NCT02360332

African American Cancer Clinical Trial Decisions: Testing Tailored Messages

Not Applicable

Completed

Conditions: Lymphoma
Leukemia
Myeloma

Interventions: Behavioral: EMR Tailoring
Behavioral: Physician Involvement
Behavioral: Survey Tailoring

First Posted Date: 2015-02-05

Last Posted Date: 2020-04-01

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 90

Registration Number: NCT02356549

Locations: 🇺🇸
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States

Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer

Phase 1

Completed

Conditions: Pancreatic Adenocarcinoma
Stage IA Pancreatic Cancer
Stage IB Pancreatic Cancer
Stage IIA Pancreatic Cancer
Stage IIB Pancreatic Cancer
Stage III Pancreatic Cancer
Recurrent Pancreatic Carcinoma

Interventions: Drug: Gemcitabine
Drug: Sorafenib
Drug: Vorinostat
Radiation: 3-Dimensional Conformal Radiation Therapy
Radiation: Intensity-Modulated Radiation Therapy
Other: RosetteSep
Other: DEPfff

First Posted Date: 2015-01-29

Last Posted Date: 2022-09-19

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 23

Registration Number: NCT02349867

Locations: 🇺🇸
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States

Randomized Controlled Trial Methods for Novel Tobacco Products Evaluation

Phase 1

Completed

Conditions: Nontherapeutic

Interventions: Other: cigarette substitute
Other: e-cigarette

First Posted Date: 2015-01-21

Last Posted Date: 2018-09-07

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 520

Registration Number: NCT02342795

Locations: 🇺🇸
Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
🇺🇸
Center for the Study of Tobacco Products, Richmond, Virginia, United States

Activity for Diabetic Polyneuropathy

Not Applicable

Conditions: Diabetic Neuropathy

Interventions: Behavioral: Supervised Exercise and Counseling
Behavioral: Standard Care Counseling

First Posted Date: 2015-01-19

Last Posted Date: 2020-05-18

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 140

Registration Number: NCT02341261

Locations: 🇺🇸
University of Kansas, Kansas City, Kansas, United States
🇺🇸
University of Utah School of Medicine, Salt Lake City, Utah, United States

Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Phase 1

Completed

Conditions: Adult Brain Glioblastoma
Adult Giant Cell Glioblastoma
Adult Gliosarcoma

Interventions: Drug: Dimethyl Fumarate
Drug: Temozolomide
Radiation: Radiation Therapy

First Posted Date: 2015-01-13

Last Posted Date: 2019-06-28

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 12

Registration Number: NCT02337426

Locations: 🇺🇸
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States

Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy

Phase 3

Terminated

Conditions: Breast Cancer - Female

Interventions: Drug: Placebo
Drug: Melatonin

First Posted Date: 2015-01-07

Last Posted Date: 2023-03-30

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 80

Registration Number: NCT02332928

Locations: 🇺🇸
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States

Atrial Appendage Closure Prospective Observational Study

Withdrawn

Conditions: Atrial Fibrillation
Left Atrial Appendage Closure

First Posted Date: 2014-12-05

Last Posted Date: 2015-06-15

Lead Sponsor: Virginia Commonwealth University

Registration Number: NCT02309268

Locations: 🇺🇸
Virginia Medical Center, Richmond, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy